mkc 231 has been researched along with amiridine in 1 studies
| Studies (mkc 231) | Trials (mkc 231) | Recent Studies (post-2010) (mkc 231) | Studies (amiridine) | Trials (amiridine) | Recent Studies (post-2010) (amiridine) |
|---|---|---|---|---|---|
| 11 | 0 | 3 | 114 | 23 | 33 |
| Protein | Taxonomy | mkc 231 (IC50) | amiridine (IC50) |
|---|---|---|---|
| Acetylcholinesterase | Electrophorus electricus (electric eel) | 0.17 | |
| Cholinesterase | Equus caballus (horse) | 0.07 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hotta, N; Iguchi, A; Miura, H; Surina-Baumgartner, DM; Tamagawa, T; Tamaya, N; Ueda, M; Uemura, K; Yoshioka, S | 1 |
1 other study(ies) available for mkc 231 and amiridine
| Article | Year |
|---|---|
Central nervous system-mediated hyperglycemic effects of NIK-247, a cholinesterase inhibitor, and MKC-231, a choline uptake enhancer, in rats.
Topics: Aminoquinolines; Animals; Blood Glucose; Central Nervous System; Choline; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Injections, Intraventricular; Male; Neostigmine; Nootropic Agents; Quinolines; Rats; Rats, Wistar; Sodium Chloride | 1999 |